PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in PharmaCyte Biotech, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +6 vs. Q3 2025
- Shares held
- 984.1K
- +550.8K (+127.1%) vs. Q3 2025
- Total value
- $712.0K
- +$292.1K (+69.6%) vs. Q3 2025
- New holders
- 7
- 5 more added
- Sold out
- 1
- 7 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 229,722 | $166.3K | 0.00% | +215,191+1,480.9% | Added |
| HRT Financial LP | 182,801 | $132.0K | 0.00% | +182,801 | New |
| Geode Capital Management, LLC | 123,844 | $89.7K | 0.00% | −2,759−2.2% | Reduced |
| Sabby Management, LLC | 100,000 | $72.4K | 0.60% | +100,000 | New |
| Renaissance Technologies LLC | 94,036 | $68.1K | 0.00% | +14,036+17.5% | Added |
| Vanguard Group Inc | 74,919 | $54.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 35,601 | $25.8K | 0.00% | +16,393+85.3% | Added |
| Schonfeld Strategic Advisors LLC | 26,178 | $19.0K | 0.00% | −22−0.1% | Reduced |
| Simplex Trading, LLC | 25,834 | $18.7K | 0.00% | +24,734+2,248.5% | Added |
| Two Sigma Securities, LLC | 24,553 | $17.8K | 0.00% | +24,553 | New |
| XTX Topco Ltd | 24,442 | $17.7K | 0.00% | +24,442 | New |
| Equitec Proprietary Markets, LLC | 22,227 | $16.1K | 0.08% | −60,500−73.1% | Reduced |
| Jane Street Group, LLC | 11,391 | $8.25K | 0.00% | +11,391 | New |
| Tower Research Capital LLC (TRC) | 4,898 | $3.55K | 0.00% | −653−11.8% | Reduced |
| UBS Group AG | 2,746 | $1.99K | 0.00% | +1,423+107.6% | Added |
| Bank of America Corp | 314 | $227 | 0.00% | −224−41.6% | Reduced |
| Advisor Group Holdings, Inc. | 303 | $219 | 0.00% | −1−0.3% | Reduced |
| Sachetta, LLC | 14 | $11 | 0.00% | 00.0% | Unchanged |
| Aviso Financial Inc. | 12 | $8 | 0.00% | +12 | New |
| BFSG, LLC | 5 | $4 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2 | $2 | 0.00% | −7−77.8% | Reduced |
| Financial Consulate, Inc | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 2 | $1 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 2 | $1 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | $1 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| MCF Advisors LLC | 1 | $1 | 0.00% | +1 | New |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 275 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Accredited Wealth Management, LLC | – | – | – | – | Not filed |